Market Overview

Morgan Stanley Upgrades Elanco Animal Health On Valuation

Share:
Morgan Stanley Upgrades Elanco Animal Health On Valuation

While Elanco Animal Health Inc’s (NYSE: ELAN) current valuation reflects the ongoing investor concerns, the focus is now likely to shift to the positives related to the Bayer transaction, prospects of margin expansion and long-term pipeline potential over 20202, according to Morgan Stanley.

The Analyst

Morgan Stanley’s David Risinger upgraded Elanco Animal Health from Equal-Weight to Overweight while reducing the price target from $34 to $32.

The Thesis

Elanco Animal Health’s shares have declined by 15% year to date, significantly underperforming the broader market and key competitor Zoetis Inc (NYSE: ZTS), Risinger said in the note.

Investors currently appear skeptical about the decision to purchase Bayer's Animal Health business for $7.6 billion, the analyst said. He added, however, that investor sentiment may turn positive as the date of deal closing approaches.

Risinger enumerated the reasons for this shift in sentiment as upward pressure on consensus earnings estimates, deal hurdles would have cleared by then and Bayer’s revenue growth prospects would have improved due to “the slowing Advantage franchise declines and potential new product pipeline launches.”

The analyst expects Elanco Animal Health’s shares to outperform the Healthcare sector, given the company’s limited exposure to “potential Washington pricing pressure.”

Price Action

Shares of Elanco Animal Health was trading almost flat at $26.61 at the time of publishing on Thursday.

Latest Ratings for ELAN

DateFirmActionFromTo
Nov 2019UpgradesEqual-WeightOverweight
Sep 2019Initiates Coverage OnOverweight
Aug 2019DowngradesBuyNeutral

View More Analyst Ratings for ELAN
View the Latest Analyst Ratings

Posted-In: David Risinger Morgan StanleyAnalyst Color Upgrades Price Target Analyst Ratings

 

Related Articles (ELAN + ZTS)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
NVDACascendMaintains240.0
NXTCBank of AmericaReiterates89.0
RNRJP MorganAssumes173.0
CARBNorthlandDowngrades23.0
GLIBACitiUpgrades80.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Option Traders Make Large Bearish Bets On Micron

Cramer On Ride-Hailing Stocks: Bullish On Lyft, Not So Much On Uber